
Anti-HIV Agents, Antitubercular Agents/therapeutic use, Anti-Infective Agents/therapeutic use, Antitubercular Agents, Acyclovir, Azithromycin, Valine/*analogs & derivatives/therapeutic use, Antiviral Agents, Azithromycin/therapeutic use, Pneumonia, Pneumocystis/drug therapy/prevention & control, Chickenpox, Anti-Infective Agents, Clarithromycin, AIDS-Related Opportunistic Infections/drug therapy/*prevention & control, Herpes Simplex/drug therapy/prevention & control, Humans, Chickenpox/drug therapy/prevention & control, Anti-HIV Agents/administration & dosage/therapeutic use, Ganciclovir, Clarithromycin/therapeutic use, Atovaquone, Mycobacterium avium-intracellulare Infection, Antiviral Agents/therapeutic use, AIDS-Related Opportunistic Infections, Pneumonia, Pneumocystis, Toxoplasmosis/drug therapy/prevention & control, Herpes Simplex, Tuberculosis, Pulmonary/drug therapy/prevention & control, Mycobacterium avium-intracellulare Infection/drug therapy/prevention & control, Rifabutin, Ganciclovir/therapeutic use, Cytomegalovirus Infections, Cytomegalovirus Infections/drug therapy/prevention & control, Drug Therapy, Combination, Acyclovir/*analogs & derivatives/therapeutic use, Trimethoprim-Sulfamethoxazole Combination/therapeutic use, Rifabutin/therapeutic use, Naphthoquinones/therapeutic use, Toxoplasmosis, Naphthoquinones
Anti-HIV Agents, Antitubercular Agents/therapeutic use, Anti-Infective Agents/therapeutic use, Antitubercular Agents, Acyclovir, Azithromycin, Valine/*analogs & derivatives/therapeutic use, Antiviral Agents, Azithromycin/therapeutic use, Pneumonia, Pneumocystis/drug therapy/prevention & control, Chickenpox, Anti-Infective Agents, Clarithromycin, AIDS-Related Opportunistic Infections/drug therapy/*prevention & control, Herpes Simplex/drug therapy/prevention & control, Humans, Chickenpox/drug therapy/prevention & control, Anti-HIV Agents/administration & dosage/therapeutic use, Ganciclovir, Clarithromycin/therapeutic use, Atovaquone, Mycobacterium avium-intracellulare Infection, Antiviral Agents/therapeutic use, AIDS-Related Opportunistic Infections, Pneumonia, Pneumocystis, Toxoplasmosis/drug therapy/prevention & control, Herpes Simplex, Tuberculosis, Pulmonary/drug therapy/prevention & control, Mycobacterium avium-intracellulare Infection/drug therapy/prevention & control, Rifabutin, Ganciclovir/therapeutic use, Cytomegalovirus Infections, Cytomegalovirus Infections/drug therapy/prevention & control, Drug Therapy, Combination, Acyclovir/*analogs & derivatives/therapeutic use, Trimethoprim-Sulfamethoxazole Combination/therapeutic use, Rifabutin/therapeutic use, Naphthoquinones/therapeutic use, Toxoplasmosis, Naphthoquinones
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
